Correia MA - Search Results

1

Cytochrome P450 turnover.

Correia MA. Correia MA. Methods Enzymol. 1991;206:315-25. doi: 10.1016/0076-6879(91)06101-8. Methods Enzymol. 1991. PMID: 1784218 No abstract available.

2

Characterization of cannabidiol-mediated cytochrome P450 inactivation.

Bornheim LM, Everhart ET, Li J, Correia MA. Bornheim LM, et al. Among authors: correia ma. Biochem Pharmacol. 1993 Mar 24;45(6):1323-31. doi: 10.1016/0006-2952(93)90286-6. Biochem Pharmacol. 1993. PMID: 8466552

3

Specifically designed thiosteroids as active-site-directed probes for functional dissection of rat liver cytochrome P450 3A isozymes.

Underwood MC, Cashman JR, Correia MA. Underwood MC, et al. Among authors: correia ma. Chem Res Toxicol. 1992 Jan-Feb;5(1):42-53. doi: 10.1021/tx00025a008. Chem Res Toxicol. 1992. PMID: 1581535

4

Degradation of rat hepatic cytochrome P-450p.

Correia MA, Sugiyama K, Yao KQ. Correia MA, et al. Drug Metab Rev. 1989;20(2-4):615-28. doi: 10.3109/03602538909103565. Drug Metab Rev. 1989. PMID: 2680399 Review. No abstract available.

5

Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4.

He K, Bornheim LM, Falick AM, Maltby D, Yin H, Correia MA. He K, et al. Among authors: correia ma. Biochemistry. 1998 Dec 15;37(50):17448-57. doi: 10.1021/bi9808464. Biochemistry. 1998. PMID: 9860860

6

Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide.

Yao K, Falick AM, Patel N, Correia MA. Yao K, et al. Among authors: correia ma. J Biol Chem. 1993 Jan 5;268(1):59-65. J Biol Chem. 1993. PMID: 8416964

7

Microsomal cytochrome P450-mediated liver and brain anandamide metabolism.

Bornheim LM, Kim KY, Chen B, Correia MA. Bornheim LM, et al. Among authors: correia ma. Biochem Pharmacol. 1995 Aug 25;50(5):677-86. doi: 10.1016/0006-2952(95)00177-2. Biochem Pharmacol. 1995. PMID: 7669071

8

Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system.

Correia MA, Davoll SH, Wrighton SA, Thomas PE. Correia MA, et al. Arch Biochem Biophys. 1992 Sep;297(2):228-38. doi: 10.1016/0003-9861(92)90666-k. Arch Biochem Biophys. 1992. PMID: 1497342

9

Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms?

Correia MA, Yao K, Wrighton SA, Waxman DJ, Rettie AE. Correia MA, et al. Arch Biochem Biophys. 1992 May 1;294(2):493-503. doi: 10.1016/0003-9861(92)90716-a. Arch Biochem Biophys. 1992. PMID: 1567205

10

Oxidative metabolism of spironolactone: evidence for the involvement of electrophilic thiosteroid species in drug-mediated destruction of rat hepatic cytochrome P450.

Decker CJ, Rashed MS, Baillie TA, Maltby D, Correia MA. Decker CJ, et al. Among authors: correia ma. Biochemistry. 1989 Jun 13;28(12):5128-36. doi: 10.1021/bi00438a033. Biochemistry. 1989. PMID: 2765527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results